December 20th, 2024: Court denies expansion of Ozempic MDL to include blood clot injury claims The Judicial Panel on Multidistrict Litigation (JPML) has recently denied a motion to expand the existing Weight Loss MDL, which currently includes drugs like Ozempic, to also cover claims related to blood clot injuries
however, this would need to be proven through additional research, he notes
Also eligible are individuals that are classified as overweight with a BMI at or exceeding 27 and also live with at least one weight-related condition, may also qualify
Life Sciences 1 min read Torrent Pharma launches oral, injectable semaglutide in India under Sembolic, Semalix The company enters the GLP-1 segment with pricing starting at 3,999 per month, including what it claims is Indias first generic oral version of the drug
So we gonna to see how this goes